← All diseases Cancer

Melanoma (metastatic)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (27)Meta-analysis (4)Treatment guideline (2)Systematic review (8)Phase 3 study (7)Randomized trial (6)Clinical trial (586)Review article (181)Early study (phase 1 or 2) (54)Case reports (243)Laboratory or animal study (45)Commentary or editorial (17)Retracted publication (2) Studies currently recruiting participants only (39)

Filter

Publications (1266)

• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cytomegalovirus (CMV) Co-infection in Treatment-Refractory Immune Checkpoint Inhibitor-Associated Colitis: A Case Report. (2026/06/21) ♡
• Global patterns of melanoma, burden attributable to ultraviolet radiation exposure, and projections to 2050 across 185 countries: A population-based study with global modeling. (2026/06/12) ♡
• Immunohistochemical Analysis of pH-Sensitive TRPV5 in Common Skin Tumors. (2026/06/11) ♡
• Living with melanoma: a study protocol for the design and participatory development of a survivorship care programme for people with metastatic melanoma. (2026/06/09) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies. (2026/06/08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey. (2026/06/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Uveal Melanoma: Changing Paradigms of Treatment. (2026/06/01) ♡
• Glycoprotein non-metastatic melanoma protein B promotes pyroptosis of macrophages induced by homocysteine associated with the upregulation of the NOX-2/ NF-κB signaling pathway. (2026/06/01) ♡
• Fractionated stereotactic re-irradiation after plaque radiotherapy (brachytherapy) failure in uveal melanoma. (2026/06/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Diffuse Amelanotic Choroidal Melanoma Mimicking Mushrooming Melanocytic Melanoma and Choroidal Metastasis in a Patient with Dual Primary Malignancies: A Case Report. (2026/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma. (2026/06/01) ♡
• Frozen melanoma tissues yield extracellular vesicles with preserved diagnostic and immunogenic properties. (2026/05/21) ♡
• Predicting of survival in metastatic melanoma patients under anti-PD-1 monotherapy using genomic mutation and copy number variation. (2026/05/18) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Investigation of oral bromelain supplementation on the healing of skin flap reconstruction after Mohs micrographic surgery (MMS) for non-melanoma skin cancers (NMSCs). (2026/05/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The immune landscape of melanoma microenvironmental crosstalk. (2026/05/11) ♡
• Local Flaps in Nasal Reconstruction Following Non-Melanocytic Skin Cancer Ablation. (2026/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Delayed diagnosis of metastatic melanoma reoccurrence: Case report. (2026/05/01) ♡
• Advanced metastatic melanoma in a young adult: A consequence of delayed diagnosis due to social barriers? (2026/04/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Triphasic Adrenocorticotropic Hormone Dynamics During Immune Checkpoint Inhibitor Therapy in a Patient With Malignant Melanoma. (2026/04/18) ♡
• Contemporary Tumor Histology Grouping for Survival Prediction of Patients With Metastatic Long-bone Disease Undergoing Surgery. (2026/04/15) ♡
• Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma. (2026/04/01) ♡
• RYK is a GPNMB receptor that drives MASH. (2026/04/01) ♡
• Machine learning-based association analysis of triglyceride-glucose index with melanoma prevalence and all-cause mortality: insights from cross-sectional NHANES 1999-2018 data and an external hospital-based dataset. (2026/03/18) ♡
• Acyl-CoA synthetase long-chain family member 4-A novel prognostic marker in cutaneous melanoma. (2026/03/16) ♡
• Combining information on degradomics and gene expression data in prospecting metastatic melanoma proteolytic signatures. (2026/03/15) ♡
• Disitamab vedotin with or without PD-1 inhibitors in pretreated patients with locally advanced or metastatic urothelial carcinoma: Identifying patients who derive additional benefit from immune combination therapy. (2026/03/01) ♡
• Evaluation of Optical Coherence Tomography for Metastatic Lymph Node Identification in Canine Oral Malignant Melanoma. (2026/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tumor immune-vascular crosstalk: synergy and translation of immune checkpoint inhibitors and anti-angiogenic agents in melanoma. (2026/02/12) ♡
• Nanoengineering of cyclic dinucleotide‑manganese complexes using biodegradable mesoporous silica nanoparticles for cancer metallo-immunotherapy. (2026/02/10) ♡
• Discontinuation of BRAF/MEK inhibitor therapy after long-lasting response: Clinical outcomes in advanced melanoma. (2026/02/05) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. [Tisotumab Vedotin - Metastatic or recurrent cervical cancer as second-line therapy]. (2026/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Interdigitating Dendritic Cell Sarcoma Arising on the Skin: An Exceedingly Rare Tumor With a Poor Prognosis. (2026/02/01) ♡
• Incensole enhances anti-tumor immunity and inhibits melanoma progression by modulating macrophage polarization and suppressing metastasis. (2026/02/01) ♡
• Prognostic Value of Systemic Inflammatory Markers in Locally Advanced or Metastatic Melanoma: A Real-World Analysis. (2026/01/28) ♡
• Intratumoral delivery of probiotic Ligilactobacillus salivarius H22A013 modulates the melanoma microenvironment and enhances trametinib efficacy. (2026/01/27) ♡
• A lung specific escape of intravascular metastatic breast cancer cells from cytotoxic T cell killing. (2026/01/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Melanoma vaccines: current R&D landscape, translational hurdles, and future outlook-a perspective drawn from 442 clinical trials. (2026/01/19) ♡
• Targeting PDPN enhances antitumor T-cell activity by disrupting β-catenin-mediated PD-L1 expression in melanoma. (2026/01/07) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hematologic immune-related adverse events in skin cancer patients treated with immune checkpoint inhibitors: a case series. (2026/01/06) ♡
• SPACA6-hosted miR-99b~125a~let-7e cluster shapes melanoma resistance by modulating mTOR-mediated immunosuppression. (2026/01/02) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Unraveling the mystery of gastric nodular mass: A rare case highlighting the diagnostic challenge of metastatic amelanotic melanoma. (2026/01/01) ♡
• Analysis of overall survival in patients with second primary malignancies following with the first diagnosis of nonmetastatic prostate cancer: A study utilizing the Surveillance, Epidemiology, and End Results database. (2026/01/01) ♡
• Harnessing the synergy of contact brachytherapy and immune checkpoint inhibitors in advanced melanoma: first reported case series. (2025/12/31) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Spontaneous cSCC Murine Model Shows Limited Response to PD-1 Blockade and Radiation Combination Therapy. (2025/12/31) ♡
• Ephrin Receptors and Ephrin Ligands in Uveal Melanoma: A Big Data Analysis Using Web Resources. (2025/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Intraocular metastasis from an anal squamous cell carcinoma: a case report. (2025/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Duodenal metastases from lung adenocarcinoma causing gastrointestinal bleeding: a rare aetiology. (2025/12/30) ♡
• Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus. (2025/12/30) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanoma. (2025/12/29) ♡
• The AKT-p21 phosphorylation signaling axis confers poor prognosis and dacarbazine resistance in melanoma. (2025/12/29) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.